NCT01032200 2021-09-28
Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Wake Forest University Health Sciences
Phase 2 Completed
Clinical Trials
9 trialsNCT01381718 2021-08-13
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
University of South Florida
Phase 2 Completed
NCT01019187 2020-04-09
Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT01011218 2018-11-29
Management of Insomnia in Breast Cancer Patients
Stanford University
Phase 2 Completed
NCT01746043 2018-06-06
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00825227 2017-11-17
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Terminated
NCT00766467 2016-07-28
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01348607 2014-02-21
Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy
University of South Florida
Phase 2 Terminated
NCT01400958 2013-12-16
Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated